Managing Seasonal Allergic Rhinitis with Medications

Updated guidelines from the 2017 Joint Task Force on Practice Parameters recommend initial treatment with an intranasal corticosteroid alone.

Sponsoring Organizations: American Academy of Allergy, Asthma, and Immunology (AAAAI); American College of Allergy, Asthma, and Immunology (ACAAI)

Target Audience: Primary care providers, otolaryngologists, allergists, and pulmonologists

Background

Seasonal allergic rhinitis affects as many as 14% of adults in the U.S. Most patients either self-treat or see primary care clinicians; only a minority of patients see allergists. Patients and physicians alike often express confusion about the best medication or combination of medications to use. This update of a 2008 guideline from the AAAAI and ACAAI provides specific guidance on pharmacologic treatment for seasonal allergic rhinitis, including for initial therapy.

Key Recommendations

For initial tr…

Reviewing Author

David J. Amrol, MD

Disclosures

Speaker’s BureauAstraZeneca; Incyte